SlideShare a Scribd company logo
1 of 26
KARAGANDA STATE MEDICALKARAGANDA STATE MEDICAL
UNIVERSITYUNIVERSITY
SUBJECT-EPIDEMIOLOGYSUBJECT-EPIDEMIOLOGY
SIWTSIWT
SUBMITTED TO: AISULUKAMAROVA
SUBMITTED BY: MANOJ
KUMAR
OM PRAKASH
GROUP- 3009
EPIDEMIOLOGYEPIDEMIOLOGY OFOF
TUBERCULOSISTUBERCULOSIS
EPIDEMIOLOGY
“The study of the distribution and
determinants of health-related states or
events in specified populations, and the
application of this study to the control of
health problems”
TUBERCULOSIS
Tuberculosis is a specific infectious
disease caused by M. tuberculosis. The
disease primarily affects lungs and causes
pulmonary tuberculosis.
 TB is spread person to person
through the air via droplet
nuclei
 M. tuberculosis may be
expelled when an infectious
person:
◦ Coughs
◦ Sneezes
◦ Speaks
◦ Sings
 Transmission occurs when
another person inhales droplet
nuclei
TB TRANSMISSIONTB TRANSMISSION
TB TRANSMISSIONTB TRANSMISSION
Transmission is defined as the spread of an
organism, such as M. tuberculosis, from one
person to another.
Probability that TB will be transmitted depends
on:
Infectiousness of person with TB disease
Environment in which exposure occurred
Length of exposure
Virulence (strength) of the tubercle bacilli
The best way to stop transmission is to:
Isolate infectious persons
Provide effective treatment to infectious
persons as soon as possible
INCUBATION PERIODINCUBATION PERIOD
The time from receipt of infection
to the development of a +ve
tuberculin test ranges from 3-6
weeks
Incubation period may be week,
month or year
Until mid-1800s, many
believed TB was
hereditary
1865 Jean Antoine-
Villemin proved TB
was contagious
1882 Robert Koch
discovered M.
tuberculosis, the
bacterium that causes
TB
HISTORY OF TBHISTORY OF TB
Mycobacterium tuberculosis
Image credit: Janice Haney Carr
1840 19201860 1900 1940 1960 1980 20001880
1993: TB cases decline1993: TB cases decline
due to increased fundingdue to increased funding
and enhanced TB controland enhanced TB control
effortsefforts
1884:1884:
First TBFirst TB
sanatoriumsanatorium
establishedestablished
in U.S.in U.S.
1865:1865:
Jean-Jean-
AntoineAntoine
VilleminVillemin
proved TB isproved TB is
contagiouscontagious
1943:1943:
StreptomycinStreptomycin
(SM) a drug used(SM) a drug used
to treat TB isto treat TB is
discovereddiscovered
1882:1882:
Robert Koch discoversRobert Koch discovers
M. tuberculosisM. tuberculosis
Mid-1980s:Mid-1980s:
Unexpected rise inUnexpected rise in
TB casesTB cases
1943-1952:1943-1952:
Two more drugs areTwo more drugs are
discovered to treatdiscovered to treat
TB: INH and PASTB: INH and PAS
TB HISTORY TIMELINETB HISTORY TIMELINE
EPIDEMIOLOGICAL INDICESEPIDEMIOLOGICAL INDICES
Indices or parameters are needed to
measure the tuberculosis problem in a
community
For planning and evaluation of control
measures
Indices are also required for
international comparison
 Following epidemiological indices are
generally used in TB :
a) Prevalence of infection:-
 It is the percentage of individual who show a
positive reaction to the standard tuberculin
test.
b) Incidence of infection (Annual infection rate):-
 It is the percentage of population under study
who will be newly infected by M. tuberculosis.
 It reflects the annual risk of being infected in a
given community.
c) Prevalence of disease (Case rate) :-
 It is the percentage of individuals who’s
sputum is positive for tubercle bacilli on
microscopic examination.
 It is the best available practical index to
estimate the number of infectious cases
or case load in a community.
d) Indices of new cases :-
 It is the percentage of new tuberculosis
cases per 1000 population occurring
during one year.
e) Prevalence of suspect cases :-
 It is based on X- Ray examination of chest.
 Drawback of this index is that radiography
cannot reveal with any certainty.
 That’s why it has no epidemiological
significance.
f) Case detection rate :-
no. of new and relapse cases in a year
estimated incidence of such cases in same year
g) Prevalence of new drug resistance
cases :-
 The patients resistance to anti-
tuberculosis drugs.
 Mortality rate :-
 The no. of deaths from TB per lakh
population was used as the index of
the TB problem in a community.
 At present time it has no significance.
SOME DEFINATIONS OF TB CASESSOME DEFINATIONS OF TB CASES
NEW CASES – A patient with sputum +ve
PTB who has never treated for TB or
has taken anti- tuberculosis drug for
less than 4 week.
RELAPSE – A patient who return smear
+ve having previously been treated for
TB and cured.
Return after default- A patient who return
sputum smear +ve after having left
treatment for at least 2 months.
TRANSFER IN- A patient recorded in another
administrative area register and transferred
into another area to continue treatment.
TRANSFER OUT- A patient who has been
transfer to another area registered and
treatment result are not known.
CURED– Initially smear +ve positive patient
who completed treatment and had –ve smear
result on at least two occasions.
COHORT- A group of patients in whom TB
has been diagnosed and who were registered
for treatment during a specified time period.
NATURAL HISTORY OF TBNATURAL HISTORY OF TB
AGENT FACTORS
AGENT
M. TUBERCULOSIS
IS A FACULTATIVE
INTRACELLULAR
PARASITE
SOURCE OF
INFECTION
(TWO SOURCES)
COMMUNICABILITY
PATIENTS ARE REMAIN
INFECTIVE AS LONG
AS THEY REMAIN
UNTREATED
HUMAN SOURCE
MOST COMMON
SOURCE
BOVINE SOURCE
INFECTION USUALLY
BY INFECTED MILK
HOST FACTORS
AGE- TB AFFECTS ALL THE AGES
SEX- MORE PREVALENT IN MALES
HERIDITY- TB IS NOT A HERIDITARY
DISEASE
NUTRIENT- MALNUTRITION IS WIDELY
PREDISPOSE TO TB
IMMUNITY- MAN HAS NO INHERITED
IMMUNITY AGAINST TB
SOCIAL FACTORS
POOR QUALITY OF LIFE
POOR HOUSING
OVERCROWDING
POPULATION EXPLOSION
UNDERNUTRITION
LACK OF EDUCATION
LARGE FAMILIES
EARLY MARRIAGES etc.
GLOBAL BURDEN OF TBGLOBAL BURDEN OF TB
2 billion infected, i.e. 1 in 3 of global population
9.4 million (139/lakh) new cases in 2008, 80% in
22 high-burden countries
About 5.7 million cases were notified through
DOTS programme during 2010
Global incidence of TB has peaked in 2004 and is
declining
1.77 million deaths in 2007, 98% in low-income
countries
1.4 million deaths in 2010
MDR-TB -prevalence in new cases around 3.6%
GLOBAL SITUATIONGLOBAL SITUATION
Since 1995, over 21 million patients have
been diagnosed and treated in DOTS
programmes.
In 2007, 5.5 million new and relapse TB
cases were initiated on treatment under
DOTS strategy.
Of 2.5 million new smear positive patients
registered in 2006, 85% were successfully
treated under DOTS.
TUBERCULOSIS IN INDIATUBERCULOSIS IN INDIA
 Estimated incidence
1.96 million new cases annually
0.8 million new smear positive cases annually
75 new smear positive PTB cases/lakh population per
year
 Estimated prevalence of TB disease
3.8 million bacillary cases in 2000
1.7 million new smear positive cases in 2000
 Estimated mortality
330,000 deaths due to TB each year
Over 1000 deaths a day
2 deaths every 3 minutes
Prevalence of TB infection
40% (~400 million) infected with M.
tuberculosis (with a 10% lifetime risk of TB
disease in the absence of HIV)
Estimated Multi-drug resistant TB
< 3% in new cases
12% in re-treatment cases
TB-HIV
~2.31 million people living with HIV
(PLWHA)
10-15% annual risk (60% lifetime risk) of
developing active TB disease in PLWHA
About 80% of TB patients are between 15-54
year of age, while two- third of the cases are
male.
India is the highest TB burden country accountingIndia is the highest TB burden country accounting
for more than one-fifth of the global incidencefor more than one-fifth of the global incidence
Indonesia
6%
Nigeria
5%
Other countries
20%
Other 13 HBCs
16% China
14%
South Africa
5%
Bangladesh
4%
Ethiopia
3%
Pakistan
3%
Phillipines
3%
India
21%
Source: WHO Geneva; WHO Report 2009: Global Tuberculosis Control; Surveillance, Planning and Financing
Global annual incidence = 9.4 million
India annual incidence = 1.96 million
India is 17th
among 22
High Burden
Countries (in terms of
TB incidence rate)
REFRENCESREFRENCES
Internet and Wikipedia
K. Park
Vivek Jain
Epidemiology

More Related Content

What's hot

Epidemiology of Tuberculosis (tb)
Epidemiology of Tuberculosis (tb)Epidemiology of Tuberculosis (tb)
Epidemiology of Tuberculosis (tb)Kareem Hussien
 
Tuberculosis revised guidelines - 2016
Tuberculosis   revised guidelines - 2016Tuberculosis   revised guidelines - 2016
Tuberculosis revised guidelines - 2016Dr.Hemant Kumar
 
Tuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat GurungTuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat GurungSamrat Gurung
 
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015Niraj Bartaula
 
Emerging and reemerging infectious diseases
Emerging and reemerging infectious diseasesEmerging and reemerging infectious diseases
Emerging and reemerging infectious diseasesarijitkundu88
 
Epidemiology of covid 19 pandemic and its control strategies
Epidemiology of covid 19 pandemic and its control strategiesEpidemiology of covid 19 pandemic and its control strategies
Epidemiology of covid 19 pandemic and its control strategiesBhoj Raj Singh
 
Concept of sufficient cause and component causes
Concept of sufficient cause and component causesConcept of sufficient cause and component causes
Concept of sufficient cause and component causesamitakashyap1
 
An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...
An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...
An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...Abraham Idokoko
 
Anti tuberculous Drugs and Patient Counseling
Anti tuberculous Drugs and Patient CounselingAnti tuberculous Drugs and Patient Counseling
Anti tuberculous Drugs and Patient CounselingYamini Shah
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillanceDr.RAJEEV KASHYAP
 
Control of communicable diseases
Control of communicable diseases Control of communicable diseases
Control of communicable diseases Rozelle Mae Birador
 

What's hot (20)

Tb burden of disease
Tb burden of diseaseTb burden of disease
Tb burden of disease
 
Epidemiology of Tuberculosis (tb)
Epidemiology of Tuberculosis (tb)Epidemiology of Tuberculosis (tb)
Epidemiology of Tuberculosis (tb)
 
Tuberculosis revised guidelines - 2016
Tuberculosis   revised guidelines - 2016Tuberculosis   revised guidelines - 2016
Tuberculosis revised guidelines - 2016
 
Public health concerns in epidemics and pandemics
Public health concerns in epidemics and pandemicsPublic health concerns in epidemics and pandemics
Public health concerns in epidemics and pandemics
 
Tuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat GurungTuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat Gurung
 
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015
 
Emerging and reemerging infectious diseases
Emerging and reemerging infectious diseasesEmerging and reemerging infectious diseases
Emerging and reemerging infectious diseases
 
Epidemiology of covid 19 pandemic and its control strategies
Epidemiology of covid 19 pandemic and its control strategiesEpidemiology of covid 19 pandemic and its control strategies
Epidemiology of covid 19 pandemic and its control strategies
 
Concept of sufficient cause and component causes
Concept of sufficient cause and component causesConcept of sufficient cause and component causes
Concept of sufficient cause and component causes
 
An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...
An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...
An Update on the DOTS Strategy to STOP Tuberculosis in our Lifetimes by Dr. I...
 
Tuberculosis among household contacts of multidrug resistant tuberculosis cas...
Tuberculosis among household contacts of multidrug resistant tuberculosis cas...Tuberculosis among household contacts of multidrug resistant tuberculosis cas...
Tuberculosis among household contacts of multidrug resistant tuberculosis cas...
 
Tb control in india
Tb control in indiaTb control in india
Tb control in india
 
Communicable disease control
Communicable disease controlCommunicable disease control
Communicable disease control
 
Anti tuberculous Drugs and Patient Counseling
Anti tuberculous Drugs and Patient CounselingAnti tuberculous Drugs and Patient Counseling
Anti tuberculous Drugs and Patient Counseling
 
Tuberculosis at glance
Tuberculosis at glanceTuberculosis at glance
Tuberculosis at glance
 
Pandemics
PandemicsPandemics
Pandemics
 
Komal hirani
Komal hiraniKomal hirani
Komal hirani
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillance
 
Control of communicable diseases
Control of communicable diseases Control of communicable diseases
Control of communicable diseases
 
Rntcp introduction
Rntcp introductionRntcp introduction
Rntcp introduction
 

Viewers also liked

HANUM -2/ddpa sem 4 utm -construction and mangment practice
HANUM -2/ddpa sem 4 utm -construction and mangment practice HANUM -2/ddpa sem 4 utm -construction and mangment practice
HANUM -2/ddpa sem 4 utm -construction and mangment practice Hanum Yusri
 
THE JAY R DIZON L PRODUCTION
THE JAY R DIZON L PRODUCTIONTHE JAY R DIZON L PRODUCTION
THE JAY R DIZON L PRODUCTIONJay R Dizon L
 
The Jay R Dizon L Production
The Jay R Dizon L ProductionThe Jay R Dizon L Production
The Jay R Dizon L ProductionJay R Dizon L
 
WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING
WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING
WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING Hanum Yusri
 
Diaspora of the moros history report
Diaspora of the moros history reportDiaspora of the moros history report
Diaspora of the moros history reportJela La
 
System of cellular immunity
System of cellular immunity System of cellular immunity
System of cellular immunity Manoj Godara
 
Aritmatika penjumlahan dan pengurangan bilangan biner presentasi
Aritmatika penjumlahan dan pengurangan bilangan biner presentasiAritmatika penjumlahan dan pengurangan bilangan biner presentasi
Aritmatika penjumlahan dan pengurangan bilangan biner presentasitaki92
 
Taxonomy of objectives
Taxonomy of objectivesTaxonomy of objectives
Taxonomy of objectivesKaye Porquillo
 
MGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYON
MGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYONMGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYON
MGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYONJela La
 

Viewers also liked (13)

Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
HANUM -2/ddpa sem 4 utm -construction and mangment practice
HANUM -2/ddpa sem 4 utm -construction and mangment practice HANUM -2/ddpa sem 4 utm -construction and mangment practice
HANUM -2/ddpa sem 4 utm -construction and mangment practice
 
THE JAY R DIZON L PRODUCTION
THE JAY R DIZON L PRODUCTIONTHE JAY R DIZON L PRODUCTION
THE JAY R DIZON L PRODUCTION
 
Robotica001 (1)
Robotica001 (1)Robotica001 (1)
Robotica001 (1)
 
The Jay R Dizon L Production
The Jay R Dizon L ProductionThe Jay R Dizon L Production
The Jay R Dizon L Production
 
Dragon Blade
Dragon BladeDragon Blade
Dragon Blade
 
WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING
WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING
WORK BREAKDOWN STRUCTURE DDPA2033 UTM CIVIL ENGINEERING
 
Diaspora of the moros history report
Diaspora of the moros history reportDiaspora of the moros history report
Diaspora of the moros history report
 
System of cellular immunity
System of cellular immunity System of cellular immunity
System of cellular immunity
 
Aritmatika penjumlahan dan pengurangan bilangan biner presentasi
Aritmatika penjumlahan dan pengurangan bilangan biner presentasiAritmatika penjumlahan dan pengurangan bilangan biner presentasi
Aritmatika penjumlahan dan pengurangan bilangan biner presentasi
 
Taxonomy of objectives
Taxonomy of objectivesTaxonomy of objectives
Taxonomy of objectives
 
ROOTS
ROOTSROOTS
ROOTS
 
MGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYON
MGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYONMGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYON
MGA SANGKAP/ ELEMENTO AT PROSESO NG KOMUNIKASYON
 

Similar to Epidemiology

PARULYADAV_BSCNURSING2NDYR_1912196 tuberculosis
PARULYADAV_BSCNURSING2NDYR_1912196 tuberculosisPARULYADAV_BSCNURSING2NDYR_1912196 tuberculosis
PARULYADAV_BSCNURSING2NDYR_1912196 tuberculosisPARULYADAV71
 
Pulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationPulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationJack Frost
 
national health program(tb and malaria )
national health program(tb and malaria )national health program(tb and malaria )
national health program(tb and malaria )Arbeena Shakir
 
07-Presentation1
07-Presentation107-Presentation1
07-Presentation1manish joya
 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1Suhail Naqvi
 
Sam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesSam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesAbhishek Sunny
 
Pharmacotherapy of TUBERCULOSIS
Pharmacotherapy of TUBERCULOSISPharmacotherapy of TUBERCULOSIS
Pharmacotherapy of TUBERCULOSISRahul Kshirsagar
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosisvinoli_sg
 
Tuberclosis pharmacotherapy
Tuberclosis pharmacotherapyTuberclosis pharmacotherapy
Tuberclosis pharmacotherapydrusama007
 

Similar to Epidemiology (20)

PARULYADAV_BSCNURSING2NDYR_1912196 tuberculosis
PARULYADAV_BSCNURSING2NDYR_1912196 tuberculosisPARULYADAV_BSCNURSING2NDYR_1912196 tuberculosis
PARULYADAV_BSCNURSING2NDYR_1912196 tuberculosis
 
Pharmacotherapy of Tuberculosis
Pharmacotherapy of TuberculosisPharmacotherapy of Tuberculosis
Pharmacotherapy of Tuberculosis
 
Pulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationPulmonary Tuberculosis Presentation
Pulmonary Tuberculosis Presentation
 
national health program(tb and malaria )
national health program(tb and malaria )national health program(tb and malaria )
national health program(tb and malaria )
 
Introduction
IntroductionIntroduction
Introduction
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
07-Presentation1
07-Presentation107-Presentation1
07-Presentation1
 
Tuberculosis.man
Tuberculosis.manTuberculosis.man
Tuberculosis.man
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Sam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesSam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciences
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosis
 
Pharmacotherapy of TUBERCULOSIS
Pharmacotherapy of TUBERCULOSISPharmacotherapy of TUBERCULOSIS
Pharmacotherapy of TUBERCULOSIS
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberclosis pharmacotherapy
Tuberclosis pharmacotherapyTuberclosis pharmacotherapy
Tuberclosis pharmacotherapy
 
TUBERCULOSIS
TUBERCULOSISTUBERCULOSIS
TUBERCULOSIS
 

Recently uploaded

What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 

Recently uploaded (20)

What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 

Epidemiology

  • 1. KARAGANDA STATE MEDICALKARAGANDA STATE MEDICAL UNIVERSITYUNIVERSITY SUBJECT-EPIDEMIOLOGYSUBJECT-EPIDEMIOLOGY SIWTSIWT SUBMITTED TO: AISULUKAMAROVA SUBMITTED BY: MANOJ KUMAR OM PRAKASH GROUP- 3009
  • 3. EPIDEMIOLOGY “The study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems” TUBERCULOSIS Tuberculosis is a specific infectious disease caused by M. tuberculosis. The disease primarily affects lungs and causes pulmonary tuberculosis.
  • 4.  TB is spread person to person through the air via droplet nuclei  M. tuberculosis may be expelled when an infectious person: ◦ Coughs ◦ Sneezes ◦ Speaks ◦ Sings  Transmission occurs when another person inhales droplet nuclei TB TRANSMISSIONTB TRANSMISSION
  • 5. TB TRANSMISSIONTB TRANSMISSION Transmission is defined as the spread of an organism, such as M. tuberculosis, from one person to another.
  • 6. Probability that TB will be transmitted depends on: Infectiousness of person with TB disease Environment in which exposure occurred Length of exposure Virulence (strength) of the tubercle bacilli The best way to stop transmission is to: Isolate infectious persons Provide effective treatment to infectious persons as soon as possible
  • 7. INCUBATION PERIODINCUBATION PERIOD The time from receipt of infection to the development of a +ve tuberculin test ranges from 3-6 weeks Incubation period may be week, month or year
  • 8. Until mid-1800s, many believed TB was hereditary 1865 Jean Antoine- Villemin proved TB was contagious 1882 Robert Koch discovered M. tuberculosis, the bacterium that causes TB HISTORY OF TBHISTORY OF TB Mycobacterium tuberculosis Image credit: Janice Haney Carr
  • 9. 1840 19201860 1900 1940 1960 1980 20001880 1993: TB cases decline1993: TB cases decline due to increased fundingdue to increased funding and enhanced TB controland enhanced TB control effortsefforts 1884:1884: First TBFirst TB sanatoriumsanatorium establishedestablished in U.S.in U.S. 1865:1865: Jean-Jean- AntoineAntoine VilleminVillemin proved TB isproved TB is contagiouscontagious 1943:1943: StreptomycinStreptomycin (SM) a drug used(SM) a drug used to treat TB isto treat TB is discovereddiscovered 1882:1882: Robert Koch discoversRobert Koch discovers M. tuberculosisM. tuberculosis Mid-1980s:Mid-1980s: Unexpected rise inUnexpected rise in TB casesTB cases 1943-1952:1943-1952: Two more drugs areTwo more drugs are discovered to treatdiscovered to treat TB: INH and PASTB: INH and PAS TB HISTORY TIMELINETB HISTORY TIMELINE
  • 10. EPIDEMIOLOGICAL INDICESEPIDEMIOLOGICAL INDICES Indices or parameters are needed to measure the tuberculosis problem in a community For planning and evaluation of control measures Indices are also required for international comparison
  • 11.  Following epidemiological indices are generally used in TB : a) Prevalence of infection:-  It is the percentage of individual who show a positive reaction to the standard tuberculin test. b) Incidence of infection (Annual infection rate):-  It is the percentage of population under study who will be newly infected by M. tuberculosis.  It reflects the annual risk of being infected in a given community.
  • 12. c) Prevalence of disease (Case rate) :-  It is the percentage of individuals who’s sputum is positive for tubercle bacilli on microscopic examination.  It is the best available practical index to estimate the number of infectious cases or case load in a community. d) Indices of new cases :-  It is the percentage of new tuberculosis cases per 1000 population occurring during one year.
  • 13. e) Prevalence of suspect cases :-  It is based on X- Ray examination of chest.  Drawback of this index is that radiography cannot reveal with any certainty.  That’s why it has no epidemiological significance. f) Case detection rate :- no. of new and relapse cases in a year estimated incidence of such cases in same year
  • 14. g) Prevalence of new drug resistance cases :-  The patients resistance to anti- tuberculosis drugs.  Mortality rate :-  The no. of deaths from TB per lakh population was used as the index of the TB problem in a community.  At present time it has no significance.
  • 15. SOME DEFINATIONS OF TB CASESSOME DEFINATIONS OF TB CASES NEW CASES – A patient with sputum +ve PTB who has never treated for TB or has taken anti- tuberculosis drug for less than 4 week. RELAPSE – A patient who return smear +ve having previously been treated for TB and cured. Return after default- A patient who return sputum smear +ve after having left treatment for at least 2 months.
  • 16. TRANSFER IN- A patient recorded in another administrative area register and transferred into another area to continue treatment. TRANSFER OUT- A patient who has been transfer to another area registered and treatment result are not known. CURED– Initially smear +ve positive patient who completed treatment and had –ve smear result on at least two occasions. COHORT- A group of patients in whom TB has been diagnosed and who were registered for treatment during a specified time period.
  • 17. NATURAL HISTORY OF TBNATURAL HISTORY OF TB AGENT FACTORS AGENT M. TUBERCULOSIS IS A FACULTATIVE INTRACELLULAR PARASITE SOURCE OF INFECTION (TWO SOURCES) COMMUNICABILITY PATIENTS ARE REMAIN INFECTIVE AS LONG AS THEY REMAIN UNTREATED HUMAN SOURCE MOST COMMON SOURCE BOVINE SOURCE INFECTION USUALLY BY INFECTED MILK
  • 18. HOST FACTORS AGE- TB AFFECTS ALL THE AGES SEX- MORE PREVALENT IN MALES HERIDITY- TB IS NOT A HERIDITARY DISEASE NUTRIENT- MALNUTRITION IS WIDELY PREDISPOSE TO TB IMMUNITY- MAN HAS NO INHERITED IMMUNITY AGAINST TB
  • 19. SOCIAL FACTORS POOR QUALITY OF LIFE POOR HOUSING OVERCROWDING POPULATION EXPLOSION UNDERNUTRITION LACK OF EDUCATION LARGE FAMILIES EARLY MARRIAGES etc.
  • 20. GLOBAL BURDEN OF TBGLOBAL BURDEN OF TB 2 billion infected, i.e. 1 in 3 of global population 9.4 million (139/lakh) new cases in 2008, 80% in 22 high-burden countries About 5.7 million cases were notified through DOTS programme during 2010 Global incidence of TB has peaked in 2004 and is declining 1.77 million deaths in 2007, 98% in low-income countries 1.4 million deaths in 2010 MDR-TB -prevalence in new cases around 3.6%
  • 21. GLOBAL SITUATIONGLOBAL SITUATION Since 1995, over 21 million patients have been diagnosed and treated in DOTS programmes. In 2007, 5.5 million new and relapse TB cases were initiated on treatment under DOTS strategy. Of 2.5 million new smear positive patients registered in 2006, 85% were successfully treated under DOTS.
  • 22. TUBERCULOSIS IN INDIATUBERCULOSIS IN INDIA  Estimated incidence 1.96 million new cases annually 0.8 million new smear positive cases annually 75 new smear positive PTB cases/lakh population per year  Estimated prevalence of TB disease 3.8 million bacillary cases in 2000 1.7 million new smear positive cases in 2000  Estimated mortality 330,000 deaths due to TB each year Over 1000 deaths a day 2 deaths every 3 minutes
  • 23. Prevalence of TB infection 40% (~400 million) infected with M. tuberculosis (with a 10% lifetime risk of TB disease in the absence of HIV) Estimated Multi-drug resistant TB < 3% in new cases 12% in re-treatment cases TB-HIV ~2.31 million people living with HIV (PLWHA) 10-15% annual risk (60% lifetime risk) of developing active TB disease in PLWHA About 80% of TB patients are between 15-54 year of age, while two- third of the cases are male.
  • 24. India is the highest TB burden country accountingIndia is the highest TB burden country accounting for more than one-fifth of the global incidencefor more than one-fifth of the global incidence Indonesia 6% Nigeria 5% Other countries 20% Other 13 HBCs 16% China 14% South Africa 5% Bangladesh 4% Ethiopia 3% Pakistan 3% Phillipines 3% India 21% Source: WHO Geneva; WHO Report 2009: Global Tuberculosis Control; Surveillance, Planning and Financing Global annual incidence = 9.4 million India annual incidence = 1.96 million India is 17th among 22 High Burden Countries (in terms of TB incidence rate)